Adaptive Phase I & II Trials

Rapid approval, flexible conduct, adaptive protocols in a MHRA accredited facility.

View service

Phase III Clinical Studies

Fast and efficient patient recruitment for Phase III clinical trials.

View service

TQT Studies

Cardiac safety assessments are built into every clinical study.

View service

Bridging Studies

Fast track your global marketing authorisations with our ethnic bridging studies.

View service

Patient Recruitment

Fast and efficient in-house team, specialising in patient recruitment.

View service

Data Management

Flexible, efficient and tailored to our clients’ needs.

View service

Gene Editing & Gene Silencing

Richmond Pharmacology is at the forefront of gene editing.

View service

Regulatory Strategy Services

Strategic guidance for faster global regulatory approvals.

View service

Pharmacovigilance

Patient safety through expert adverse event monitoring

View service

Latest news

Richmond Pharmacology Appoints Adam Hurd as Operations Director

August 17, 2026
Richmond Pharmacology, the London-based contract research organisation and global leader in early phase clinical trials, announces the appointment of Adam Hurd as Operations Director
Read more

Upcoming Event

Women's Health Horizons 2026

22 September 2026
Richmond Pharmacology is pleased to join the Women’s Health Horizons London Summit hosted by the Royal College of Obstetricians and Gynaecologists in London, 22 September 2026
View event